Search research articles
Contact Us
Filters
Showing results (151-160 of 2,139) with videos related to
Page
of 214
Sort By:
Current Atherosclerosis Reports
|
February 21, 2009
GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects
Melanie Sulistio, Curtis Carothers, Mandeep Mangat, et al.
Current Atherosclerosis Reports
|
February 21, 2009
The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk
Fadi G Hage, Alexander J Szalai
Current Atherosclerosis Reports
|
February 21, 2009
Drug-eluting stents and vulnerable plaque
Mehmet Cilingiroglu, Faisal Khan
Current Atherosclerosis Reports
|
October 27, 2009
Carbohydrate-restricted diets for obesity and related diseases: an update
Christy L Boling, Eric C Westman, William S Yancy
Current Atherosclerosis Reports
|
October 27, 2009
Nutritional supplements and serum lipids: does anything work?
Mary P McGowan, Suzanne Proulx
Current Atherosclerosis Reports
|
September 11, 2016
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja-Riitta Taskinen, Jan Borén
Current Atherosclerosis Reports
|
May 14, 2017
Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations
Bhavin B Adhyaru, Terry A Jacobson
Current Atherosclerosis Reports
|
April 15, 2018
Adoption and Design of Emerging Dietary Policies to Improve Cardiometabolic Health in the US
Yue Huang, Jennifer Pomeranz, Parke Wilde, et al.
Current Atherosclerosis Reports
|
June 30, 2017
Is Obesity the New Hypertension? Parallels in the Evolution of Obesity and Hypertension as Recognized Disease States
Devika Umashanker, Alpana P Shukla, Katherine H Saunders, et al.
Current Atherosclerosis Reports
|
November 1, 2005
The effects of low-fat, high-carbohydrate diets on plasma lipoproteins, weight loss, and heart disease risk reduction
Ernst J Schaefer, Joi A Gleason, Michael L Dansinger
Page
of 214
Search research articles
Search
Showing results (151-160 of 2,139) with videos related to
Sort By:
Page
of 214
Current Atherosclerosis Reports
|
February 21, 2009
GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects
Melanie Sulistio, Curtis Carothers, Mandeep Mangat, et al.
Current Atherosclerosis Reports
|
February 21, 2009
The role of C-reactive protein polymorphisms in inflammation and cardiovascular risk
Fadi G Hage, Alexander J Szalai
Current Atherosclerosis Reports
|
February 21, 2009
Drug-eluting stents and vulnerable plaque
Mehmet Cilingiroglu, Faisal Khan
Current Atherosclerosis Reports
|
October 27, 2009
Carbohydrate-restricted diets for obesity and related diseases: an update
Christy L Boling, Eric C Westman, William S Yancy
Current Atherosclerosis Reports
|
October 27, 2009
Nutritional supplements and serum lipids: does anything work?
Mary P McGowan, Suzanne Proulx
Current Atherosclerosis Reports
|
September 11, 2016
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja-Riitta Taskinen, Jan Borén
Current Atherosclerosis Reports
|
May 14, 2017
Role of Non-Statins, LDL-C Thresholds, and Special Population Considerations: A Look at the Updated 2016 ACC Consensus Committee Recommendations
Bhavin B Adhyaru, Terry A Jacobson
Current Atherosclerosis Reports
|
April 15, 2018
Adoption and Design of Emerging Dietary Policies to Improve Cardiometabolic Health in the US
Yue Huang, Jennifer Pomeranz, Parke Wilde, et al.
Current Atherosclerosis Reports
|
June 30, 2017
Is Obesity the New Hypertension? Parallels in the Evolution of Obesity and Hypertension as Recognized Disease States
Devika Umashanker, Alpana P Shukla, Katherine H Saunders, et al.
Current Atherosclerosis Reports
|
November 1, 2005
The effects of low-fat, high-carbohydrate diets on plasma lipoproteins, weight loss, and heart disease risk reduction
Ernst J Schaefer, Joi A Gleason, Michael L Dansinger
Page
of 214